vTv Therapeutics, based in High Point, NC, is a clinical stage biotechnology company focused on developing innovative drug candidates to enhance the lives of individuals with diabetes. Their lead product, TTP399, shows promise in reducing hypoglycemic episodes in type 1 diabetes patients.
With a strong commitment to advancing diabetes treatment, vTv Therapeutics aims to make a significant impact on patient care through their cutting-edge pipeline of therapeutic solutions. Through ongoing research and development efforts, the company strives to address the unmet needs of individuals living with diabetes.
Generated from the website